Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the role of the MALT1-RC3H1 axis in regulating GPX4 protein stability. | Proc Natl Acad Sci U S A | 2025 | 39739814 | PubTator, text mining | PubMed |
| Glucose Upregulates ChREBP via Phosphorylation of AKT and AMPK to Modulate MALT1 and WISP1 Expression. | J Cell Physiol | 2025 | 39530300 | PubTator, text mining | PubMed |
| In silico study of some plant compounds as potential anticancer agents targeting MALT1 allosteric domain. | J Biomol Struct Dyn | 2025 | 39319376 | PubTator, text mining | PubMed |
| [Long Term Clinical Outcomes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Single Center Study]. | Korean J Helicobacter Up Gastrointest Res | 2024 | 40503274 | PubTator, text mining | PubMed |
| miR-21-loaded bone marrow mesenchymal stem cell-derived exosomes inhibit pyroptosis by targeting MALT1 to repair chemotherapy-induced premature ovarian insufficiency. | Cell Biol Toxicol | 2024 | 39707056 | PubTator, text mining | PubMed |
| Enforced CARD11/MALT1 signaling in dendritic cells triggers hemophagocytic lymphohistiocytosis. | Proc Natl Acad Sci U S A | 2024 | 39661061 | PubTator, text mining | PubMed |
| Research on cross-provincial power trading strategy considering the medium and long-term trading plan. | Sci Rep | 2024 | 39627406 | PubTator, text mining | PubMed |
| Adaptor protein 3BP2 regulates gene expression in addition to the ubiquitination and proteolytic activity of MALT1 in dectin-1-stimulated cells. | J Biol Chem | 2024 | 39542253 | PubTator, text mining | PubMed |
| A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluid. | Respir Med Case Rep | 2024 | 39502446 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Endoscopic morphology of gastric MALT lymphoma correlate with API2/MALT1 fusion and predict treatment response after helicobacter pylori eradication. | BMC Gastroenterol | 2024 | 39482577 | PubTator, text mining | PubMed |
| Transformed gastric mucosa-associated lymphoid tissue lymphoma originating in the colon and developing metachronously after Helicobacter pylori eradication: A case report. | World J Gastrointest Oncol | 2024 | 39473962 | PubTator, text mining | PubMed |
| Beyond traditional magnetic resonance processing with artificial intelligence. | Commun Chem | 2024 | 39465320 | PubTator, text mining | PubMed |
| Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population. | J Clin Exp Hematop | 2024 | 39462546 | PubTator, text mining | PubMed |
| Transcriptome Profiling Associated with CARD11 Overexpression in Colorectal Cancer Implicates a Potential Role for Tumor Immune Microenvironment and Cancer Pathways Modulation via NF-κB. | Int J Mol Sci | 2024 | 39408697 | PubTator, text mining | PubMed |
| MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression. | bioRxiv | 2024 | 39386586 | PubTator, text mining | PubMed |
| The role of structure in regulatory RNA elements. | Biosci Rep | 2024 | 39364891 | PubTator, text mining | PubMed |
| A20 intrinsically influences human effector T-cell survival and function by regulating both NF-κB and JNK signaling. | Eur J Immunol | 2024 | 39359035 | PubTator, text mining | PubMed |
| MALT1 Inhibitors for Treating Cancer and Immunological Diseases. | ACS Med Chem Lett | 2024 | 39291001 | PubTator, text mining | PubMed |
| Effect of Priming With Toll-Like Receptor 3 Agonist on Expression of Long Noncoding RNAs in Human Wharton Jelly Mesenchymal Stem Cells. | Exp Clin Transplant | 2024 | 39223813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=6